Abiraterone Acetate Tablet
Product Images NDC 72603-111

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Abiraterone Acetate (NDC 72603-111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure.jpg (Structure)

Chemical structure of abiraterone acetate is shown, illustrating its molecular framework with rings and functional groups, including an acetate moiety and a pyridine ring.*

FDA Label Image

Carton500mg

Packaging label for Abiraterone Acetate Tablets, USP 500 mg by Northstar Rx LLC. The green and white label indicates film-coated tablets in a package containing 60 tablets. Storage instructions specify 20° to 25°C with authorized excursions. Manufactured by Glenmark Pharmaceuticals Limited, India. The label includes drug strength prominently in red and a barcode.*

FDA Label Image

Figure1.jpg (Figure1)

Kaplan-Meier overall survival curves comparing Abiraterone acetate versus placebo in a clinical study (COU-AA-301) over time, shown as percentage survival versus time to death in months. The chart depicts survival trends for patients treated with Abiraterone acetate and placebo, including numbers at risk at various time points.*

FDA Label Image

Figure2.jpg (Figure2)

A Kaplan-Meier overall survival curve chart comparing subjects without death over months from randomization between two groups: abiraterone acetate and placebo. The chart illustrates survival trends over a 60-month period with separate survival lines for abiraterone acetate and placebo groups.*

FDA Label Image

Figure3.jpg (Figure3)

A Kaplan-Meier survival curve comparing percent of subjects without radiographic progression or death over months from randomization for abiraterone acetate versus placebo. The x-axis represents months from randomization (0 to 18), and the y-axis shows percentage of subjects without progression or death (0 to 100%). The graph includes subject counts at various time points below the x-axis for each group.*

FDA Label Image

Figure4.jpg (Figure4)

A Kaplan-Meier survival curve chart comparing the percent survival of subjects without death over time in months from randomization between abiraterone acetate and placebo groups. It includes a table indicating the number of subjects at risk at various time points for both groups.*

FDA Label Image

Image 01

Packaging label for Abiraterone Acetate Tablets, USP 250 mg by Northstar Rx LLC. The label shows NDC 72603-110-01 and indicates 120 tablets per container. It includes a warning for women who are or may be pregnant to avoid handling without gloves. Storage instructions and manufacturing details are also present on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.